NCT Number: NCT00337766
Desmopressin in Cardiac Surgery
Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring transfusions of blood products.
Desmopressin (DDAVP), already used for patients with von Willebrand syndrome, could reduce bleeding and transfusion requirements in these patients when administered ev (0.3 mg/kg) in 20-30 minutes postoperatively.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–100 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- undergoing cardiac surgery
- excessive bleeding
Exclusion criteria
- age<18 y
- not signing written consent
Treatment and study plan
Placebo
DrugPrimary outcomes
-
Reduce transfusions
Secondary outcomes
-
Reduced bleeding
-
Reduce time on mechanical ventilation
-
Reduced ICU and Hospital stay
-
Reduced mortality
Sponsors and collaborators
Lead sponsor
Università Vita-Salute San Raffaele
Other
Registry information
Official study title
Efficacy of Desmopressin (1-deamin0-8-D-arginine-vasopressin) in Reducing Active Microvascular Bleeding After Cardiac Surgery
Important dates
- Study start
- 2006
- Primary completion
- 2009
- Study completion
- 2010
- First posted
- Jun 16, 2006
- Registry last updated
- Oct 21, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
BiZact Tonsillectomy in the Pediatric Population
NCT04725305
Hemorrhage, Neurologic Manifestations
Houston, Texas, United States
View Trial DetailsTonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial
NCT03793816
Handling, Hemorrhage
Vienna, Austria
View Trial DetailsClinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery
NCT04588350
Blood Loss, Blood Loss, Surgical
Bordeaux, France
View Trial DetailsEffect of Tonsillar Pillar Closure on Postoperative Pain and Bleeding Risk After Tonsillectomy
NCT00394849
Hemorrhage, Neurologic Manifestations
Indianapolis, Indiana, United States
View Trial Details